Tag:

Moderna

Moderna stock jumps after hantavirus vaccine update

Moderna shares rose 14.38% in Thursday morning trading following positive Phase 1 results for its mRNA hantavirus vaccine, which was well-tolerated and produced strong immune responses at all dose levels—an important milestone since no FDA-approved hantavirus vaccine currently exists.

08 May 2026-21:14
EU approves Moderna's dual flu-COVID shot for seniors

21 Apr 2026-18:17
Moderna sues Pfizer, BioNTech over COVID-19 vaccine patents

27 Aug 2022-11:10
EU medicines agency recommends approval of Moderna’s COVID-19 vaccine for children age 6-11

26 Feb 2022-13:36
Moderna's COVID-19 "Spikevax" vaccine gets full US approval

31 Jan 2022-19:58
Moderna improves forecast for 2022 sales from COVID-19 vaccine

10 Jan 2022-19:12
EU strikes deal with Moderna for quicker COVID-19 vaccine supplies

16 Dec 2021-13:53
Pfizer-BioNTech, Moderna get US approval for COVID booster shots

19 Nov 2021-22:58
Moderna COVID shot could be used in U.S. children, teens within weeks

27 Oct 2021-22:43
Moderna notes good COVID-19 vaccine response in kids aged 6-11

27 Oct 2021-00:48

Prev Next